Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Meta-Analysis
. 2020 Oct;34(10):e23618.
doi: 10.1002/jcla.23618. Epub 2020 Oct 19.

Ferritin in the coronavirus disease 2019 (COVID-19): A systematic review and meta-analysis

Affiliations
Meta-Analysis

Ferritin in the coronavirus disease 2019 (COVID-19): A systematic review and meta-analysis

Linlin Cheng et al. J Clin Lab Anal. 2020 Oct.

Abstract

Objective: The coronavirus disease 2019 (COVID-19) has rapidly developed into a pandemic. Increased levels of ferritin due to cytokine storm and secondary hemophagocytic lymphohistiocytosis were found in severe COVID-19 patients. Therefore, the aim of this study was to determine the role of ferritin in COVID-19.

Methods: Studies investigating ferritin in COVID-19 were collected from PubMed, EMBASE, CNKI, SinoMed, and WANFANG. A meta-analysis was performed to compare the ferritin level between different patient groups: non-survivors versus survivors; more severe versus less severe; with comorbidity versus without comorbidity; ICU versus non-ICU; with mechanical ventilation versus without mechanical ventilation.

Results: A total of 52 records involving 10 614 COVID-19-confirmed patients between December 25, 2019, and June 1, 2020, were included in this meta-analysis, and 18 studies were included in the qualitative synthesis. The ferritin level was significantly increased in severe patients compared with the level in non-severe patients [WMD 397.77 (95% CI 306.51-489.02), P < .001]. Non-survivors had a significantly higher ferritin level compared with the one in survivors [WMD 677.17 (95% CI 391.01-963.33), P < .001]. Patients with one or more comorbidities including diabetes, thrombotic complication, and cancer had significantly higher levels of ferritin than those without (P < .01). Severe acute liver injury was significantly associated with high levels of ferritin, and its level was associated with intensive supportive care, including ICU transfer and mechanical ventilation.

Conclusions: Ferritin was associated with poor prognosis and could predict the worsening of COVID-19 patients.

Keywords: COVID-19; comorbidity; diagnosis; ferritin; mortality; severity.

PubMed Disclaimer

Conflict of interest statement

None.

Figures

FIGURE 1
FIGURE 1
Flowchart of the literature selection
FIGURE 2
FIGURE 2
Forest plot of the ferritin level between more severe and less severe COVID‐19 patients. ARDS: acute respiratory distress syndrome
FIGURE 3
FIGURE 3
Sensitivity analysis of ferritin levels between severe and non‐severe COVID‐19 patients
FIGURE 4
FIGURE 4
Forest plot of the ferritin level between non‐survivors and survivors among COVID‐19 patients. ARDS, acute respiratory distress syndrome
FIGURE 5
FIGURE 5
Sensitivity analysis of ferritin levels between non‐survivors and survivors among COVID‐19 patients
FIGURE 6
FIGURE 6
Forest plot of the ferritin levels between groups with different baseline information: comorbidity and gender. CVD, cardiovascular disease; DVT, deep venous thrombosis; VTE, venous thromboembolism
FIGURE 7
FIGURE 7
Forest plot of the ferritin levels between groups with or without intensive supportive care among COVID‐19 patients. A, Forest plot of the ferritin levels between ICU patients and non‐ICU patients. B, Forest plot of the ferritin levels between mechanical ventilation and without mechanical ventilation among COVID‐19 patients. ICU, intensive care unit

References

    1. Zhou P, Yang X‐L, Wang X‐G, et al. A pneumonia outbreak associated with a new coronavirus of probable bat origin. Nature. 2020;579:270‐273. 10.1038/s41586-020-2012-7 - DOI - PMC - PubMed
    1. Zhu N, Zhang D, Wang W, et al. A novel coronavirus from patients with pneumonia in China. N Engl J Med. 2019;382:727‐733. 10.1056/NEJMoa2001017 - DOI - PMC - PubMed
    1. World Health Organization . https://covid19.who.int/. Accessed June 17, 2020.
    1. Li H, Liu L, Zhang D, et al. SARS‐CoV‐2 and viral sepsis: observations and hypotheses. Lancet. 2020;395(10235):1517–1520. 10.1016/S0140-6736(20)30920-X - DOI - PMC - PubMed
    1. Moore BJB, June CH. Cytokine release syndrome in severe COVID‐19. Science. 2020;368(6490):473–474. 10.1126/science.abb8925 - DOI - PubMed

MeSH terms